Clinical utility of eslicarbazepine: current evidence
Gaetano Zaccara,1 Fabio Giovannelli,1,2 Massimo Cincotta,1 Alessia Carelli,3 Alberto Verrotti31Department of Medicine, Unit of Neurology, Florence Health Authority, Florence, Italy; 2Department of Neuroscience, Psychology, Pharmacology and Child Health (NEUROFARBA), University of F...
Saved in:
Main Authors: | Zaccara G (Author), Giovannelli F (Author), Cincotta M (Author), Carelli A (Author), Verrotti A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Healthcare Resource Utilization Pre- and Post-Initiation of Eslicarbazepine Acetate Among Pediatric Patients with Focal Seizure: Evidence from Routine Clinical Practice
by: Mehta D, et al.
Published: (2020) -
Eslicarbazepine acetate: An efficacy and safety as an antiepileptic drug in clinical trials and open studies
by: Martyna Stefaniak, et al.
Published: (2022) -
Social cognition and prefrontal cognitive function in patients with epilepsy treated with eslicarbazepine acetate
by: Laura Abraira, et al.
Published: (2017) -
Inhibitory Effect of Eslicarbazepine Acetate and S-Licarbazepine on Nav1.5 Channels
by: Theresa K. Leslie, et al.
Published: (2020) -
Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures
by: Martin E Brown, et al.
Published: (2010)